Screener
West Pharmaceutical Services WST Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's net debt?
- West Pharmaceutical Services (WST) reported net debt of -$119.3M in Q2 2026.
- How has West Pharmaceutical Services's net debt changed year-over-year?
- West Pharmaceutical Services's net debt increased by 40.8% year-over-year, from -$201.5M to -$119.3M.
- What is the long-term trend for West Pharmaceutical Services's net debt?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's net debt has grown at a 9.9% compound annual growth rate (CAGR), from -$289.8M to -$465.1M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about West Pharmaceutical Services's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude